baber/WOPTO huggingface dataset:
Patent NZ-543505-A (NZ)
Title: Fast frequency hopping with a code division multiplexed pilot in an OFDMA system
Inventor: AGRAWAL AVNEESH
IPC: H04L5/02
Filed: 2004-05-07
Abstract: A method and apparatus is disclosed for receiving a wideband pilot in a wireless multi-carrier communication system comprising obtaining a sequence of received chips that include a time division multiplexed (TDM) sequence of received pilot and data chips, demultiplexing the sequence of received chips to obtain a sequence of received pilot chips and a sequence of received data chips, processing the sequence of received pilot chips with a pseudo-random number (PN) code to obtain a sequence of chip-spaced gain values based on channel gain estimates, and processing the sequence of received data chips in accordance with a demodulation scheme and with the channel response estimated to obtain recovered data symbols.
Patent NZ-546032-A (NZ)
Title: Dura substitute and a process for producing the same using Acetobacter xylinum
Inventor: DAMIEN CHRISTOPHER JAMES
IPC: A61L27/20
Filed: 2004-08-23
Abstract: Disclosed is a method for producing a dural substitute, comprising: (a) producing a cellulosic sheet using Acetobacter xylinum; (b) removing contaminants from the cellulosic sheet by contacting the cellulosic sheet with a caustic solution; (c) rinsing the cellulosic sheet with water; and (d) at least partially dehydrating the. cellulosic sheet by (i) freezing moisture in the cellulosic sheet; (ii) melting the frozen moisture; and (iii) removing the melted moisture as liquid water from the cellulosic sheet. Reference has been directed by the Commissioner under section 16 to patent specification 546033.
Patent NZ-548225-A (NZ)
Title: Inhalant formulation containing sulfoakyl ether cyclodextrin and corticosteroid
Inventor: PIPKIN JAMES D
IPC: A61K9/12
Filed: 2004-12-31
Abstract: Disclosed is an inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution, however, it can be stored as a dry powder, ready-to-use solution, or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus.
Patent NZ-548509-A (NZ)
Title: Photonic crystal defect cavity biosensor
Inventor: CUNNINGHAM BRIAN T
IPC: G02B6/122
Filed: 2005-01-06
Abstract: A biosensor and method of testing using the sensor is provided. The sensor is formed from a photonic crystal having defect cavities formed in a periodic pattern in the device. A localised maximum of electromagnetic field intensity is produced in the defect region in response to incident light on the crystal at a resonant frequency. The crystal is used to test fluid containing a sample.
Patent NZ-550738-A (NZ)
Title: Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
Inventor: DURRANT LINDA GILLIAN
IPC: A61K39/395
Filed: 2005-05-11
Abstract: Provided is an antibody against SC104 binding to sialyltetraosyl carbohydrate, with specified sequences for the CDRs. The antibody is useful for treating against tumours and can be combined with cancer drugs doxorubicin, paclitaxel. 5-fluorouracil, irinotecan and cisplatin.
Patent NZ-552432-A (NZ)
Title: Resequencing pathogen microarray
Inventor: AGAN BRIAN
IPC: G16B30/10
Filed: 2005-07-05
Abstract: Disclosed is a resequencing DNA microarray comprising multiple groups of oligonucleotide primers of a length ranging from 13 to 70 nucleotides immobilized to a solid phase support, wherein each group of oligonucleotide primers is selected to span a particular region of a distinct reference sequence, occupy a discrete area of the array termed a tiled region and comprise at least four sets of primers arranged in a parallel fashion within said discrete area of the array, wherein the sequences selected for tiling are "prototypes" representing a family or group of adenoviruses or group of influenza viruses. Also disclosed are methods of detecting the presence of a drug-resistance marker in a microorganism or presence of a microorganism belonging to a particular class of organism species or subspecies in an unknown sample. Further disclosed is a method of routine diagnosis of common respiratory pathogens and a method of estimating the relative amount of a pathogen in a biological sample.
Patent NZ-552645-A (NZ)
Title: Superconducting composite wire made from magnesium diboride
Inventor: GRASSO GIOVANNI
Filed: 2004-07-30
Abstract: A superconducting composite wire with superconductive phase of magnesium diboride, comprising a plurality of filaments of magnesium diboride within an outer .metallic sheath is disclosed. The superconducting composite wire comprises a core of conductive metal selected from copper and silver; the plurality of filaments, in which each filament comprises a core of magnesium diboride, is placed around the conductive metal core; the outer metallic sheath for containment and mechanical reinforcement, surrounds the plurality of filaments; and at least one layer of metal chemically compatible with magnesium diboride and capable of acting as an obstacle to the diffusion of the conductive metal of the conductive metal core towards the filaments at a temperature of at least 700°C. The layer is applied a) as a coating of the conductive metal core and/or b) as a coating of the filaments, and/or as a coating of the magnesium diboride core of the filaments.
Patent NZ-554125-A (NZ)
Title: Polymer powder, process for layer-by-layer moldless production of three dimentional shaped articles
Inventor: MONSHEIMER SYLVIA
Filed: 2007-03-26
Abstract: A process for production of a layer-by-layer moldless production powder is disclosed, the production process comprising the mixing of a polymer or copolymer with at least one water-soluble polymeric polyol, the dissolution of the mixture in water to form a dispersion, the isolation of the polymer particles or copolymer particles from the dispersion, and the washing and drying of the isolated polymer particles or isolated copolymer particles, wherein the polymer or copolymer comprises a PEEK, a PAEK, a PSU, a PPSU, a polyamide, an aliphatic or aromatic polyester, an aliphatic, cycloaliphatic, or aromatic polyamide, a copolyamide, or a mixture thereof and the polymeric polyol is selected from a group comprising polyethylene glycol and polyvinyl alcohol. Also disclosed is the use of said powder in a process for the layer-by-layer moldless production of a three-dimensional shaped article, in which regions of the respective powder layer are selectively melted via input of electromagnetic energy.
Patent NZ-555667-A (NZ)
Title: Storage bag with fluid separator
Inventor: BERGMAN CARL L
IPC: B65D85/07
Filed: 2005-12-16
Abstract: An open storage bag 100 comprises two flexible sidewalls 102, 104 joined together at the respective side 110, 112 and bottom 114 edges to provide an interior volume 106. Interlocking closure strips 126, 128 are provided at the top of each side wall 102, 104. One side wall 102 has a region 132/134 of increased elasticity. This region 132/134 is provided with a one way valve 130 that communicates with the interior space 106. The region 132/134 can be adjusted between an elastically expanded position where the valve 130 is placed away from the side wall 102, and an elastically recovered position where the valve 130 is located within the plane of the side wall 102. This arrangement has the advantage of allowing folding of the bag 100 for compact packing during distribution.
Patent NZ-555831-A (NZ)
Title: Novel hydantoin derivatives as metalloproteinase inhibitors
Inventor: GABOS BALINT
IPC: C07D/
Filed: 2005-12-14
Abstract: Disclosed is an imidazolidinone derivative of formula (I), wherein the substituents are as defined in the specification. The compound is a metalloproteinase inhibitor. Also disclosed is the use of the compound for treating an obstructive airways disease such as asthma or chronic obstructive pulmonary disease, or for treating rheumatoid arthritis, osteoarthritis, atherosclerosis, cancer, or multiple sclerosis.
Patent NZ-560761-A (NZ)
Title: An hydraulic pump for making vehicle suspension adjustments coupled to a hydrauic system where the pump in a first configuration is capable of pumping a quantity of fluid into the hydraulic system and in a second configuration is capable of pumping a quantity of fluid from the hydraulic system
Inventor: MUIR STEPHEN BARRY
IPC: B60G17/06
Filed: 2007-08-20
Abstract: A hydraulic pump for coupling to a hydraulic system, where the hydraulic system is suitable for making adjustments to a vehicle chassis or suspension, is disclosed. The hydraulic pump is capable of, when in a first configuration, allowing a user to pump a predetermined quantity of fluid into the hydraulic system, and in a second configuration, is capable of allowing a user to pump a predetermined quantity of fluid from the hydraulic system. The hydraulic pump includes a handle, a reciprocating shaft with an internal accumulator, a ball valve assembly, and a bore that the reciprocating shaft operates in.
Patent NZ-560999-A (NZ)
Title: Electronic spray coating control device
Inventor: MAUCHLE FELIX
IPC: B05B16/00
Filed: 2006-03-06
Abstract: An electronic spray-coating control device implementing a spray-coating method is provided. The device contains: a number of programs from a first group of programs each containing several adjustable parameters; manually driven parameter setting elements to set parameter reference values for the adjustable parameters; optical display units to automatically display the set parameter reference values; at least one program, from a second group of programs, that includes at least one adjustable parameter and at least one fixed parameter; at least one manually driven program selecting element for alternatively switching ON each time either one of the programs from the first group of programs or of the second group of programs. At least one adjustable parameter of the second group of programs also is an adjustable parameter of the first group of programs. The at least one fixed parameter of the second group of programs is an adjustable parameter of the first group of programs. The manually driven parameter setting elements include, for each adjustable parameter, a first key-like setting element for raising the particular parameter value and a second key-like setting element for lowering the particular parameter value.
Patent NZ-561417-A (NZ)
Title: Drying and milling apparatus and processing plant
Inventor: POTTER PATRICK
IPC: B02C13/00
Filed: 2007-09-13
Abstract: A drying and milling apparatus includes a housing and a rotatable section. The housing has an air or gas inlet and a product inlet at a first end and a product outlet at a second end. The rotatable section has a plurality of blades which extend radially from a hub portion of the rotatable section and are adapted to rotate within the housing and to break up and to mill any product that is introduced into the housing. The product inlet is configured to direct any incoming product directly onto the blades of the rotatable section. Also disclosed is a sewerage processing plant incorporating at least one drying and milling apparatus and a method of drying and milling substantially dewatered sewage.
Patent NZ-569550-A (NZ)
Title: Alcohol-in-oil type emulsion comprising a multivalent metal salt
Inventor: FAIYAZIANNASAB FLORA
IPC: A61K8/06
Filed: 2006-12-27
Abstract: Disclosed is an alcohol-in-oil type emulsion comprising i) a multivalent metal salt, ii) a lower-alcohol phase and iii) an oil phase, wherein said oil phase comprises one or more oil and/or fat products selected from a hydrogenated oil obtained from a vegetable source or any derivative thereof or any similar products synthetically produced. Also disclosed is a method for producing a alcohol-in-oil type emulsion, said method comprising the steps of: (i) providing an oil phase, (ii) providing a suspension of a multivalent metal salt in an alcohol phase, (iii) mixing the oil phase provided in step (i) with the suspension provided in step (ii) to obtain a mixture, (iv) providing a further suspension of a multivalent metal salt in an alcohol phase, and (v) mixing the mixture obtained in step (iii) with the further suspension of the multivalent metal salt in an alcohol phase provided in step iv) to obtain the alcohol-in-oil type emulsion. Also disclosed is the use of the alcohol-in-oil type emulsion for use in antiperspirant and for treating hyperhidrosis.
Patent NZ-573429-A (NZ)
Title: Post driver control with plural control input control system requiring the use of two hands
Inventor: FAIRBROTHER JAMES ERNEST
IPC: F16P3/18
Filed: 2009-12-03
Abstract: Disclosed is a post or pile driving apparatus. The apparatus comprises: a monkey (2) to drive a post (4) either directly or via a post cap (3); and a plural control input control system for controlling the movement of the monkey. Movement of the monkey during a driving stroke requires the operator to simultaneously employ both hands to operate the control system. The requirement ensures that the operator's hand cannot be between the post/post cap and the monkey, when the monkey is operating at driving speed. The monkey can be lifted and lowered more slowly than the driving stroke speed by the use of an operator's single hand.
Patent NZ-575548-A (NZ)
Title: Heterocyclic inhibitors of c-Met and uses thereof
Inventor: ARONOV ALEXANDER
IPC: C07D513/04
Filed: 2007-09-18
Abstract: Disclosed is a 5-mercapto-4-amino-4H-1,2,4-triazol-3-yl)ethylcarbamate of formula (I) or a salt, prodrug thereof, wherein LA, Y1 or Y2, Z, R1, R2, R3 and X is defined in the specification for treating colon cancer, gastric adenocarcinoma, bladder cancer, breast cancer, kidney cancer, liver cancer, lung cancer, thyroid cancer, cancer of the head and neck, prostate cancer, pancreatic cancer, cancer of the CNS, gliobastoma, or atherosclerosis.
Patent NZ-576672-A (NZ)
Title: Iron (iii)-carbohydrate based phosphate adsorbent
Inventor: AMBUHL MICHAEL
IPC: C01G49/00
Filed: 2007-12-12
Abstract: Disclosed is an lron(lll)-based phosphate adsorbent comprising: i) an adsorbent base material which is starch; ii) polynuclear iron(III) oxide hydroxides; iii) a soluble carbohydrate which is a glucose derivative, partially incorporated into the polynuclear iron(III) oxide hydroxides; and iv) optionally, a carbonate; wherein the iron(III)-based phosphate adsorbent has a phosphate binding capacity of at least about 140 mg adsorbed phosphate by 1 g of phosphate adsorbent, and wherein said iron(III)-based phosphate adsorbent is isolated by spray drying. Also disclosed are methods of preparation.
Patent NZ-579223-A (NZ)
Title: Bacteria inoculation system with earthworm humus, used as treatment of contaminated water (inoculom)
Inventor: FUENTES ALEX MANUEL VILLAGRA
IPC: C02F3/10
Filed: 2006-08-11
Abstract: Provided is an apparatus for inoculating different bacterial flora from earthworm humus for treating liquid and semi-liquid waste, the apparatus including a container, wherein said container includes: a first layer comprising earthworm humus; a second layer including a cellulose or celluloid material underlying the first layer; a third layer including an inert porous material underlying the second layer; the apparatus also including a means to distribute liquid and semi-liquid waste onto or under the first layer of the container to percolate through the second and third layers, and a means to drain the treated liquid and semi-liquid waste from the container.
Patent NZ-584145-A (NZ)
Title: 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1,4'] bipyridinyl-2'-ones
Inventor: CID-NUNEZ JOSE MARIA
IPC: A61K31/4545
Filed: 2008-09-12
Abstract: Disclosed is a compound having the formula (I) or a stereo chemically isomeric form thereof, wherein: R1 is C1-6alkyl; or C1-3alkyl substituted with C3-7cycloalkyl, phenyl, or phenyl substituted with halo, trifluoromethyl or trifluoromethoxy; R2 is halo, trifluoromethyl, C1-3alkyl or cyclopropyl; R3 is hydrogen, fluoro, hydroxyl, hydroxyC1-3alkyl, hydroxyC1-3alkyloxy, fluoroC1-3alkyl, fluoroC1-3alkyloxy or cyano; and Ar is unsubstituted phenyl; or phenyl substituted with n radicals R4 wherein n is 1, 2 or 3; or a pharmaceutically acceptable salt or a solvate thereof.
Patent NZ-584473-A (NZ)
Title: Agent for promoting osteogenesis and/or inhibiting bone resorption
Inventor: MORITA YOSHIKAZU
IPC: A23K1/165
Filed: 2004-09-30
Abstract: Provided is the use of ribonuclease in the manufacture of a medicament for promoting osteogenesis and/or inhibiting bone resorption. The medicament can be formulated as a food, drink or feed.
Patent NZ-587034-A (NZ)
Title: Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands
Inventor: DANDU REDDEPPAREDDY
IPC: C07D491/10
Filed: 2009-01-28
Abstract: Disclosed is a compound of Formula (I) e.g. CyclobutyI-6-(4,5-dihydro-4,5- cyclobutylpyridazin-3-one )-spiro [1,3-benzodioxine-2,4' -piperidine or a stereoisomeric form, mixture of stereoisomeric forms, or a pharmaceutically acceptable salt thereof, wherein: R1 is cycloalkyl; W is -CH2-, -CH2CH2-, or -CH2-O -; k is 0, 1, or 2; m is 0, 1, or 2; and the sum of m and k is 1, 2, or 3; y2 = y3 is -C(X)=CH- or -CH=C(X)-; X is R2, OR2, -alkyl-R2, -O-alkyl-R2, -NHR2, -NHC(=O)R2, or -NHC(=O)NHR2; R2 is defined in the specification; R9 , at each occurrence, is independently F, CI, Br, CI-C4 alkyl, or alkoxy; R10 is F, CI, Br, alkyl, or alkoxy; n is 0, 1,2, or 3; and z is 0, 1, 2, 3, 4, 5, or 6 for the treatment of a disorder selected from the group consisting of narcolepsy or sleep/wake disorders, feeding behavior disorders, eating disorders, obesity, cognition disorders, arousal disorders, memory disorders, mood disorders, mood attention alteration, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease/dementia, schizophrenia, pain, stress, migraine, motion sickness, depression, psychiatric disorders, epilepsy, gastrointestinal disorders, respiratory disorders, inflammation, and myocardial infarction.
Patent NZ-592460-A (NZ)
Title: Programmable lock cylinder assembly with reset actuator aligned with keyway
Inventor: RAO AJEYA S
IPC: E05B15/14
Filed: 2011-04-21
Abstract: Disclosed is a programmable lock cylinder assembly including a lock housing having a body defining a tubular opening; a cylinder plug having a body mounted for rotation within the tubular opening, the cylinder plug including a single keyway extending therein; a locking member in the cylinder plug and moveable between a locked position where the cylinder plug is rotationally locked relative to the housing and an unlocked position where the cylinder plug is rotationally moveable relative to the housing. The assembly includes a plurality of pin sets, each pin set having a keyway pin component and a locking pin component and positioned in the cylinder plug such that a portion of each keyway pin component extends across the single keyway. Each keyway pin component is selectively engagable with a respective locking pin component. The assembly also includes a re-combinating member engaged with one of the components of each pin set and moveable between a first position where the keyway pin components are engaged with the locking pin components and a second position where the keyway pin components are disengaged from the locking pin components. The assembly further includes a reset actuator positioned within the cylinder plug with a portion aligned with the single keyway. The reset actuator is moveable between an engaged position where the re-combinating member is locked relative to the cylinder plug and a non-engaged position where the re-combinating member is moveable relative to the cylinder plug. The locking member includes has a sidebar biased radially outward and received in a groove along the lock housing in the locked position. Each locking pin component includes a rotatable toothed gear defining a locking sidebar notch configured to receive the sidebar in the unlocked position.
Patent NZ-592613-A (NZ)
Title: Method for treating or preventing thrombosis using >150 mg to 300 mg b.i.d. of dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
Inventor: REILLY PAUL A
IPC: A61K31/4439
Filed: 2009-11-10
Abstract: 592613 Disclosed herein is the use of dabigatran etexilate, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the prevention of stroke in patients suffering from atrial fibrillation wherein the patient has no risk factors for major bleeding events, wherein the use comprises the administration 5 of a dosage of >150 mg b.i.d. to 300 mg b.i.d. of dabigatran etexilate, or a pharmaceutically acceptable salt thereof.
Patent NZ-593210-A (NZ)
Title: Controlling output voltages of power generators at a common node to minimise power loss
Inventor: ANDRESEN BJORN
IPC: H02P9/00
Filed: 2011-06-01
Abstract: A method for controlling a power production entity (109) comprising generating electric power signals at a plurality of power production entities (109), measuring power levels of the power signals, modifying the power signals, supplying the modified power signals to a common node (103) and adjusting the operating voltage of at least one power production entity (109) based on the voltage at the common node (103) and the measured power levels of the individual power production entities (109). The operating voltage is adjusted such that the power loss caused by the modifying and/or supplying is minimised. The adjusting of the operating voltage is performed such that at least two adjusted operating voltages are different. This adjustment process is performed iteratively using the voltage at the common node (103) as a feedback signal.
Patent NZ-593826-A (NZ)
Title: Apparatus and method for the preservation of pancreatic tissue and islet cells for transplantation
Inventor: MATSUMOTO SHINICHI
IPC: A01N1/02
Filed: 2009-12-23
Abstract: Disclosed is an apparatus when used in storing organs, tissues, or cells when used in transplantation in which the organs, tissues, or cells are suspended in a solution for maintaining viability and the organs, tissues, or cells are cooled in a refrigeration unit for the entire duration of storage, wherein the refrigeration unit is capable of maintaining the temperature in the apparatus within less than 0.5 degree centigrade from the set temperature. Further disclosed is a method of preserving an organ or tissue used in transplantation comprising: · obtaining a previously harvested organ or tissue for transplantation; · placing the organ or tissue in a preservation solution; · cooling the organ or tissue to a pre-selected temperature; · maintaining the organ or tissue at the pre-selected temperature for the duration of storage, wherein maintaining the organ or tissue is performed in an apparatus, and the apparatus is capable of maintaining the temperature in the apparatus within less then 0.5 degree from the set temperature; and · providing the organ or tissue for later transplantation.
Patent NZ-597191-A (NZ)
Title: Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
Inventor: PAVLIAK VILIAM
IPC: A61K31/702
Filed: 2010-06-22
Abstract: 597191 Disclosed is an immunogenic polysaccharide-protein conjugate comprising a Staphylococcus aureus capsular polysaccharide conjugated to a carrier protein, wherein the polysaccharide has a molecular weight of between 70 kDa and 800 kDa or between 70 kDa and 300 kDa.